Agonist, dose-response curve

Fig. 8. Agonist, dose—response curves, (a) For an agonist where a value of 10 M is indicated at the concentration giving 50% response, (b) For an agonist alone, Aq, and in the presence of increasing amounts of irreversible receptor antagonists, B—F. There is a progressive rightward shift of the dose—response curve prior to reduction of maximum response. This pattern is consistent with the presence of a receptor reserve.

The basis of this model is the experimental fact that most agonist dose-response curves are hyperbolic in nature. The reasoning for making this assumption is as follows. If agonist binding is governed by mass action, then the relationship between the agonist-receptor complex and response must either be linear or hyperbolic as well. Response is thus defined as... 

FIGURE 6.1 Effects of antagonists on agonist dose-response curves, (a) Surmountable antagonism with no diminution of maxima and no limiting antagonism (competitive antagonists). 

There are patterns of dose-response curves that preclude Schild analysis. The model of simple competitive antagonism predicts parallel shifts of agonist dose-response curves with no diminution of maxima. If this is not observed it could be because the antagonism is not of the competitive type or some other factor is obscuring the competitive nature of the antagonism. The shapes of dose-response curves can prevent measurement of response-independent... 

Antagonists can produce varying combinations of dextral displacement and depression of maxima of agonist dose-response curves. The concentration-related effect of an antagonist on the system response to a single concentration of agonist constitutes what will be referred to as an inhibition curve. One of the most straightforward examples... 

In the presence of a competitive antagonist, the EC50 of the agonist dose-response curve will be shifted to the right by a factor equal to the dose ratio. This is given by the Schild equation as [B]/Kb-I-1, where the concentration of the antagonist is [B] and KB is the equilibrium dissociation constant of the antagonist-receptor complex ... 

Surmountable antagonism, an antagonist-induced shift to the right of an agonist dose-response curve with no diminution of the maximal response to the agonist (observed with simple competitive antagonists and some types of allosteric modulators). 

When a series of agonist dose-response curves are plotted on a log scale the x-axis reflects which of the following ... 

Which of the following is/are true regarding competitive inhibitors a cause a shift to the right of the agonist dose-response curve... 

---